lobbying_activities: 3481823

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3481823	242d5db5-fceb-4893-b92c-197974c6aada	Q4	LMH STRATEGIC SOLUTIONS	401108183	REGENXBIO INC.	2025	fourth_quarter	PHA	Prescription drug payment reform. Pharmaceutical supply chain.	Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2026-01-12T17:10:57-05:00